175 related articles for article (PubMed ID: 12717190)
1. Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
Kyles AE; Gregory CR; Griffey SM; Bernsteen L; Pierce J; Lilja HS; Morris RE
Transplantation; 2003 Apr; 75(8):1128-33. PubMed ID: 12717190
[TBL] [Abstract][Full Text] [Related]
2. The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Dec; 38(10):3239-40. PubMed ID: 17175234
[TBL] [Abstract][Full Text] [Related]
3. Significant prolongation of renal allograft survival by delayed combination therapy of FK778 with tacrolimus in nonhuman primates.
Qi S; Zhu S; Xu D; Wang X; Ouyang J; Jiang W; Vu MD; Bilolo K; Ma A; Johnson S; Daloze P; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Apr; 75(8):1124-8. PubMed ID: 12717189
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs.
Kyles AE; Gregory CR; Griffey SM; Jackson J; Bernsteen L; Morris RE
Vet Surg; 2002; 31(4):358-66. PubMed ID: 12094350
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of leflunomide in the canine renal transplantation model.
McChesney LP; Xiao F; Sankary HN; Foster PF; Sharma S; Haklin M; Williams JW
Transplantation; 1994 Jun; 57(12):1717-22. PubMed ID: 8016874
[TBL] [Abstract][Full Text] [Related]
7. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
[TBL] [Abstract][Full Text] [Related]
8. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
Lirtzman RA; Gregory CR; Levitski RE; Griffey SM; Yeh LS; Patz JD; Morris RE
Transplant Proc; 1996 Apr; 28(2):945-7. PubMed ID: 8623474
[No Abstract] [Full Text] [Related]
9. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
[TBL] [Abstract][Full Text] [Related]
10. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts.
Vu MD; Qi S; Wang X; Jiang W; Ma A; Xu D; Bekersky I; Fitzsimmons WE; Wu J; Chen H
Transplantation; 2003 May; 75(9):1455-9. PubMed ID: 12792496
[TBL] [Abstract][Full Text] [Related]
12. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs.
Jin MB; Nakayama M; Ogata T; Fujita M; Mino K; Taniguchi M; Suzuki T; Shimamura T; Furukawa H; Todo S
Surgery; 2002 Jul; 132(1):72-9. PubMed ID: 12110798
[TBL] [Abstract][Full Text] [Related]
13. Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study.
Zonta S; Alessiani M; Viganò J; Doni M; Bardone M; Dominioni T; De Martino M; Scaglione M; Vicini E; Filisetti C; Biroli A; Bottazzi A; Villa C; Morbini P; Dionigi P
Transplant Proc; 2007; 39(6):2021-3. PubMed ID: 17692681
[TBL] [Abstract][Full Text] [Related]
14. The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
Rintala JM; Savikko J; Rintala SE; von Willebrand E
Transplant Proc; 2006 Oct; 38(8):2719-21. PubMed ID: 17098049
[TBL] [Abstract][Full Text] [Related]
15. Microemulsified cyclosporine-based immunosuppression for the prevention of acute renal allograft rejection in unrelated dogs: preliminary experimental study.
Bernsteen L; Gregory CR; Kyles AE; Griffey SM; Patz J
Vet Surg; 2003; 32(3):213-9. PubMed ID: 12784197
[TBL] [Abstract][Full Text] [Related]
16. FK778 and tacrolimus combination therapy to control acute rejection after pig intestinal transplantation.
Alessiani M; Abbiati F; Zonta S; Zitelli E; Bardone M; Cobianchi L; Viganò J; Doni M; Mazzilli M; Dominioni T; Kabiri D; Bottazzi A; Morbini P; Molinaro MD; Dionigi P
Transplant Proc; 2006; 38(6):1809-11. PubMed ID: 16908288
[TBL] [Abstract][Full Text] [Related]
17. The effect of FK778 on the progression of chronic allograft nephropathy in a rat model.
Lutz J; Huang H; Deng M; Wagner B; Roos M; Schmaderer C; Strobl M; Heemann U
Transplantation; 2007 Mar; 83(6):741-6. PubMed ID: 17414707
[TBL] [Abstract][Full Text] [Related]
18. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
[TBL] [Abstract][Full Text] [Related]
20. FK778 controls acute rejection after rat liver allotransplantation showing positive interaction with FK506.
Yamamoto S; Okuda T; Yamasaki K; Tanaka H; Takemura S; Minamiyama Y; Ikeda K; Hirohashi K; Suehiro S
Transplant Proc; 2005; 37(1):126-9. PubMed ID: 15808570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
